In particular, we found that the core circadian gene CRY1 is up-regulated in samples from high-risk ZAP-70+/CD38+ CLL patients as compared to their ZAP-70−/CD38− counterparts which are characterized by a more benign clinical course [8], [9]. Here, CRY1 is linked to B-cell chronic lymphocytic leukemia.